Literature DB >> 15888616

Fibropolycystic liver disease: CT and MR imaging findings.

Giuseppe Brancatelli1, Michael P Federle, Valérie Vilgrain, Marie-Pierre Vullierme, Daniele Marin, Roberto Lagalla.   

Abstract

Fibropolycystic liver disease encompasses a spectrum of related lesions of the liver and biliary tract that are caused by abnormal embryologic development of the ductal plates. These lesions (congenital hepatic fibrosis, biliary hamartomas, autosomal dominant polycystic disease, Caroli disease, choledochal cysts) can be clinically silent or can cause signs and symptoms such as cholangitis, portal hypertension, gastrointestinal bleeding, infections, and space-occupying masses. The different types of fibropolycystic liver disease demonstrate characteristic findings at computed tomography (CT) and magnetic resonance (MR) imaging. Patients with congenital hepatic fibrosis typically have imaging evidence of liver morphologic abnormalities, varices, splenomegaly, renal lesions, and other associated ductal plate abnormalities. Biliary hamartomas usually manifest as multiple cysts that are nearly uniform in size and measure up to 15 mm in diameter. Autosomal dominant polycystic disease typically manifests as an enlarged and diffusely cystic liver. In Caroli disease, cystic or fusiform dilatation of the intrahepatic ducts is seen, as well as the "central dot sign," which corresponds to a portal vein branch protruding into the lumen of a dilated bile duct. Choledochal cyst manifests as a fusiform or cystic dilatation of the extrahepatic bile duct. Awareness of these CT and MR imaging features is essential in detecting and differentiating between various fibropolycystic liver diseases and can assist in proper management.

Entities:  

Mesh:

Year:  2005        PMID: 15888616     DOI: 10.1148/rg.253045114

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  36 in total

1.  Symptomatic bile duct hamartomas: surgical management in an MRI driven practice.

Authors:  Elliot B Tapper; Diego Martin; N Volkan Adsay; Bobby Kalb; David Kooby; Juan M Sarmiento
Journal:  J Gastrointest Surg       Date:  2010-05-18       Impact factor: 3.452

2.  Biliary duct hamartomas in polycystic liver disease.

Authors:  Alexander Schlachterman; Jonathan Hussain; Roberto Firpi
Journal:  BMJ Case Rep       Date:  2015-08-13

3.  Nephronophthisis 13: implications of its association with Caroli disease and altered intracellular localization of WDR19 in the kidney.

Authors:  Jiwon M Lee; Yo Han Ahn; Hee Gyung Kang; I I Soo Ha; Kyoungbun Lee; Kyung Chul Moon; Joo Hoon Lee; Young Seo Park; Yong Mee Cho; Jun-Seok Bae; Nayoung K D Kim; Woong-Yang Park; Hae I I Cheong
Journal:  Pediatr Nephrol       Date:  2015-03-01       Impact factor: 3.714

Review 4.  Choledochal cysts: part 2 of 3: Diagnosis.

Authors:  Janakie Singham; Eric M Yoshida; Charles H Scudamore
Journal:  Can J Surg       Date:  2009-12       Impact factor: 2.089

Review 5.  Clinical and molecular features of Joubert syndrome and related disorders.

Authors:  Melissa A Parisi
Journal:  Am J Med Genet C Semin Med Genet       Date:  2009-11-15       Impact factor: 3.908

Review 6.  Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.

Authors:  Luca Fabris; Romina Fiorotto; Carlo Spirli; Massimiliano Cadamuro; Valeria Mariotti; Maria J Perugorria; Jesus M Banales; Mario Strazzabosco
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08       Impact factor: 46.802

Review 7.  Evaluation of hepatic cystic lesions.

Authors:  Marten A Lantinga; Tom J G Gevers; Joost P H Drenth
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

Review 8.  Paediatric chronic liver diseases: how to investigate and follow up? Role of imaging in the diagnosis of fibrosis.

Authors:  Danièle Pariente; Stéphanie Franchi-Abella
Journal:  Pediatr Radiol       Date:  2010-04-30

Review 9.  Magnetic resonance imaging of pancreaticobiliary diseases in children: from technique to practice.

Authors:  Sudha A Anupindi; Nancy A Chauvin; Asef Khwaja; David M Biko
Journal:  Pediatr Radiol       Date:  2016-05-26

10.  Hepatic von Meyenburg complex: a trigger of severe portal hypertension.

Authors:  Shuhei Yoshida; Kazutaka Kurokohchi; Takuya Ueno; Morihiko Yoshino; Masahiko Shimada; Tsutomu Masaki
Journal:  Liver Int       Date:  2008-10-14       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.